We are live on ! Find out more
YTEN

Yield10 Bioscience, Inc. Common Stock
YTEN

Delisted

YTEN was delisted on the 15th of May, 2024.

Back to rankings

16 hedge funds and large institutions have $13.5M invested in Yield10 Bioscience, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
+16
Holders Change %
–
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$4.07M +$4.83M +50 New
State Farm Mutual Automobile Insurance
2
State Farm Mutual Automobile Insurance
Illinois
$3.28M +$3.87M +40 New
OIM
3
Oracle Investment Management
Connecticut
$2.35M +$2.8M +29 New
BIT
4
BlackRock Institutional Trust
California
$846K +$967K +10 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$679K +$773K +8 New
FA
6
FCG Advisors
New Jersey
$572K +$677K +7 New
GC
7
GMT Capital
Georgia
$287K +$387K +4 New
BCM
8
Bridgeway Capital Management
Texas
$227K +$290K +3 New
Geode Capital Management
9
Geode Capital Management
Massachusetts
$185K +$193K +2 New
Morgan Stanley
10
Morgan Stanley
New York
$122K +$96.7K +1 New
AG
11
Aperio Group
California
$118K +$96.7K +1 New
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$114K +$96.7K +1 New
Northern Trust
13
Northern Trust
Illinois
$90K +$96.7K +1 New
Renaissance Technologies
14
Renaissance Technologies
New York
$90K +$96.7K +1 New
Bank of New York Mellon
15
Bank of New York Mellon
New York
$69K +$96.7K +1 New
Jacobs Levy Equity Management
16
Jacobs Levy Equity Management
New Jersey
$49K +$96.7K +1 New
MCM
17
McRae Capital Management
New Jersey
$35K – – –
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$33K – – –
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$27K – – –
Citigroup
20
Citigroup
New York
$26K – – –
State Street
21
State Street
Massachusetts
$26K – – –
U
22
UBS
Switzerland
$23K – – –
HC
23
Highmount Capital
New York
$17K – – –
Jane Street
24
Jane Street
New York
$16K – – –
Deutsche Bank
25
Deutsche Bank
Germany
$15K – – –
1
2

YTEN Hedge Fund Activity: Q2 2013 in Review

16 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q2 2013, worth a combined $13.5M.

Buyers outnumbered sellers: 16 funds opened new YTEN positions and 0 closed out — a net gain of 16 holders — while 0 added to existing stakes and 0 trimmed.

  • 16 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $13.5M of Yield10 Bioscience, Inc. Common Stock stock for Q2 2013.
  • 16 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +16 holders.

Based on aggregated 13F filings for Q2 2013.